Informationen:
Fehler:
ID
23465
Beschreibung
Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00530621
Link
https://clinicaltrials.gov/show/NCT00530621
Stichworte
Versionen (1)
- 06.07.17 06.07.17 -
Hochgeladen am
6. Juli 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-small Cell Lung Cancer NCT00530621
Eligibility Non-small Cell Lung Cancer NCT00530621
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-small Cell Lung Cancer NCT00530621
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
ID.1
Item
laboratory confirmed diagnosis of nsclc with locally advanced or metastatic disease which cannot be cured.
boolean
C0007131 (UMLS CUI [1,1])
C0278987 (UMLS CUI [1,2])
C0278987 (UMLS CUI [1,2])
ID.2
Item
patients must have disease which progressed after 1 prior systemic cytotoxic chemotherapy regimen for advanced disease.
boolean
C0278940 (UMLS CUI [1])
ID.3
Item
at least 1 measurable lesion.
boolean
C0221198 (UMLS CUI [1])
ID.4
Item
must have stopped all previous systemic therapies for cancer for at least 2 weeks prior to enrollment.
boolean
C0087111 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,2])
ID.5
Item
must be able to follow study guidelines and be able to show up for appointments.
boolean
C1321605 (UMLS CUI [1])
ID.6
Item
treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry.
boolean
C0013230 (UMLS CUI [1])
ID.7
Item
previous treatment with enzastaurin or pemetrexed.
boolean
C1327830 (UMLS CUI [1,1])
C0210657 (UMLS CUI [1,2])
C0210657 (UMLS CUI [1,2])
ID.8
Item
concurrent administration of any other antitumor therapy.
boolean
C2986475 (UMLS CUI [1])
ID.9
Item
inability to swallow tablets
boolean
C0566357 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
ID.10
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])